USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Organoclick AB

USPTO PatentsView assignee record - 11 granted patents across 15 technology areas, active 2015–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: D06M (TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS).

11
Total patents granted
15
CPC technology areas
12.6
Avg claims per patent
+167%
5-year filing velocity

The verdict

Organoclick holds 11 US patents across 15 technology areas, rank #24,922 of 50,000 tracked assignees.

#24,922
of 50,000 US assignees by volume
Top 34%
by Innovation Score (40.9/100)
12.6
avg claims per patent
+167%
filing velocity, last 5 yrs

Portfolio overview

Organoclick AB has been granted 11 US utility patents between 2015 and 2025, placing Organoclick AB at rank #24,922 across all assignees tracked by PlainPatent. This portfolio spans 15 distinct Cooperative Patent Classification (CPC) subclasses, averaging 12.6 claims per patent with primary concentration in D06M (TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS). As a Foreign Corporation, Organoclick AB is one of the more focused assignees in the PatentsView dataset. By volume, Organoclick sits between Onkos Surgical, Inc. (11 patents, rank #24,918) and Otitopic Inc. (11 patents, rank #24,926) - the closest US assignees by grant volume. The composite Innovation Score of 40.9/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 8 grants, compared with 3 in the 2015–2019 window, a +167% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Organoclick AB's 12.6 average claims per patent sits within the typical range for solid legal coverage without excessive prosecution cost, while concentration in 15 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Organoclick AB against peers pursuing similar technology classes.

Who files at Organoclick's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Organoclick holds 11 patents at rank #24,922, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Organoclick

By rank, the assignees closest to #24,922 in granted patent volume.

Leaders in D06M (Treatment)

Other assignees with the most granted patents in Organoclick's primary technology class.

Organoclick's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

41 Top 34% higher than 66% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). This entry sits in this band. 50–60: 5,058 US assignees (10%). Above this entry. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201520162019202020212022202320242025 1
USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table
Organoclick AB patent grants by year, 2015–2025
Year Patents Granted Share of Period
2015 1 9.1%
2016 1 9.1%
2019 1 9.1%
2020 1 9.1%
2021 1 9.1%
2022 2 18.2%
2023 2 18.2%
2024 1 9.1%
2025 1 9.1%

Which technologies does Organoclick AB patent most?

Top 15 of 15 technology areas

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Standard
Velocity Accelerating

Where it ranks

Overall rank by patents

#24,922

Across all tracked assignees

Innovation Score

40.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Organoclick AB hold?
Organoclick AB holds 11 US granted patents filed between 2015 and 2025, spanning 15 technology areas.
What is Organoclick AB's Innovation Score?
Organoclick AB has an Innovation Score of 40.9 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Organoclick AB focus on?
Organoclick AB's top technology area is D06M (TREATMENT, NOT PROVIDED FOR ELSEWHERE IN CLASS D06, OF FIBRES, THREADS, YARNS, FABRICS, FEATHERS OR FIBROUS GOODS MADE FROM SUCH MATERIALS) with 7 patents. The company has filed patents in 15 CPC subclasses total.
Is Organoclick AB's patent filing rate increasing or decreasing?
Organoclick AB's recent filing velocity is +167% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Organoclick AB's patents?
Organoclick AB's patents average 12.6 claims each. This falls within the standard range, providing solid legal coverage.
How is the Organoclick AB patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

How to use this portfolio

Organoclick's 11 grants land it in the top 34% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Organoclick ranks #24,922 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in D06M - see who else leads that technology area. D06M leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.